The incoming administration of President-elect Joe Biden should build on executive actions implemented under the Defense Production Act amid the coronavirus pandemic and expand DPA authorities to further support the country's industrial base, Jerry McGinn, executive director of George Mason University's Center for Government Contracting, ...
Centerpoint has received a five-year, $116M contract to provide a range of cybersecurity support services to help the Department of Health and Human Services secure information technology infrastructure....
General Dynamics' (NYSE: GD) information technology business has won a potential five-year, $78M task order to help the Department of Health and Human Services manage the national child support program, G2Xchange Health reported Friday....
Hologic has secured a $119M contract to increase production capacity for diagnostic kits and test consumables in support of government efforts to sustain the U.S. industrial base through the coronavirus pandemic....
Palantir Technologies (NYSE: PLTR) is working on software for a new system that could help federal health officials track the production, administration and distribution of COVID-19 vaccines, The Wall Street Journal reported Thursday....
Katrina Tuisamatatele, who spent 12 years at the Department of Veterans Affairsâ office of information and technology, has joined Halfaker and Associates as deputy executive vice president of health operations....
Private equity firm Welsh, Carson, Anderson & Stowe has made an investment in GovernmentCIO, a provider of technology and digital platforms to the federal health information technology services market, to support the latterâs organic growth initiatives and client base expansion efforts....
Medical diagnostic technology maker Cue Health has been awarded a $481M other transaction agreement by the Department of Defense to increase manufacturing capacity for testing kits meant to detect COVID-19 infections....
The National Institutes of Health has issued a solicitation for the third iteration of the potential $49M NIH Business and Professional Support Services contract vehicle....
AstraZeneca has secured a $486M contract from the departments of Health and Human Services and Defense to further develop and test a pair of monoclonal antibodies as potential COVID-19 treatment. The company will use the funds to conduct large-scale production and Phase 3 trials of the experimental AZD7442 combo drug to help prevent or treat SARS-C...
